FDA
-
-
-
-
-
-
-
Moderna (MRNA) call put ratio 14 calls to 1 put with a focus on May 22 weekly 52, 55 and 57 calls
-
-
-
-
-
-
-
Moderna presents melanoma therapy data showing 83% response rate
-
-
-
-
-
-
-
Moderna (MRNA) PT Raised to $30 at RBC Capital
-
-
-
-
-
-
-
Moderna raises 2025 revenue forecast to $1.9 billion
-
-
-
-
-
-
-
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
-
-
-
-
-
-
-
Piper Sandler on Moderna (MRNA): 'Project Revenue Growth to Resume'
-
-
-
-
-
-
-
Moderna vaccine shows strong immune response against LP.8.1 variant
-
325,585 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

